Home
Site Map
Search:
About Us
Overview
Management Team
Collaborations & Contractors
Business Strategy
Investors
Products & Technology
Product Pipeline
Scientific Rationale
Clinical Development Programs
Intellectual property
Markets
Obesity
Antipsychotic drug induced weight gain
Newsroom
Press Releases
Media Coverage
Contact Us
About Us
Products & Technology
Markets
Newsroom
Contact Us
Press Releases
Media Coverage
Media Coverage
17.07.2007
Solving a Weighty Problem
04.09.2006
Obecure receives FDA approval for PHASE II Clinical Trials
27.04.2006
Obecure Metabolite Twice As Effective
Bio-Light: Element in Obecure drug for obesity twice as effective as original compound
01.04.2006
A new Israeli solution for a weighty problem
26.03.2006
Obecure May Proceed to Phase 2 Clinical Trials
Bio-Light: FDA has given permission to file request to proceed directly to Phase 2 Clinical trials
16.03.2006
Obecure Term Sheet to Raise Up to $1.5M
Bio-Light: Obecure Raises Capital Based on $20 Million Valuation
02.02.2006
Obecure Reports New Findings
©2007 All Rights Reserved to Obecure Ltd.
Disclaimer
Created by
Virtual Point Ltd.
